In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

Background: Risk factors for severe respiratory syncytial virus (RSV) disease include prematurity, congenital heart disease, chronic lung disease, and immunocompromised states. There is no ...

Through the Dren Bio deal, SNY intends to expand its immunology pipeline and establish itself as a leading immunology company ...

RSV is still a threat, but Corewell Health’s downtown Grand Rapids children’s hospital is feeling the effects of one of ...

“We know that infant RSV infections can lead to serious complications including hospitalization, intubation, and chronic respiratory disease,” Blauvelt said. “Prenatal RSV vaccination and ...

A new study has uncovered a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response ...

Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...

Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...